Introduction to Pharmacology
The route of drug administration critically determines onset, intensity, duration, and bioavailability of therapeutic agents. Selection of the appropriate route depends on drug characteristics (molecular weight, lipophilicity, stability), patient factors (consciousness, GI function, vascular access), and clinical urgency. Routes are broadly classified as enteral (via GI tract), parenteral (bypassing GI tract), topical, inhalational, and transdermal, each offering distinct pharmacokinetic profiles and clinical applications.
📋 Abbreviations Used in This Article
- PO: Per Os (oral, by mouth)
- IV: Intravenous
- IM: Intramuscular
- SC/SubQ: Subcutaneous
- GI: Gastrointestinal
- CNS: Central Nervous System
- CSF: Cerebrospinal Fluid
📑 Classification of Administration Routes
Broad categories based on drug entry pathway:
Major Route Categories
- Enteral: Via GI tract (oral, sublingual, buccal, rectal)
- Parenteral: Bypasses GI tract (IV, IM, SC, intrathecal)
- Topical/Local: Applied to body surfaces (skin, eye, ear)
- Inhalational: Via respiratory tract (lungs)
- Transdermal: Through skin for systemic absorption
Selection Factors
- Clinical Urgency: Emergency = IV; chronic = oral
- Drug Properties: Acid-labile drugs avoid oral route
- Patient Status: Unconscious/vomiting patients need parenteral
- Desired Effect: Local vs systemic therapy
💊 Enteral Routes
Drug administration via the gastrointestinal tract:
| Route | Onset/Bioavailability | Advantages | Disadvantages | Examples |
|---|---|---|---|---|
| Oral (PO) | Slow (30–90 min); variable bioavailability | Safe, non-invasive, economical, convenient | First-pass metabolism, food/pH effects, not for vomiting/unconscious | Aspirin, amoxicillin, metformin |
| Sublingual/Buccal | Rapid (minutes); avoids first-pass | Fast onset, non-invasive | Limited to potent drugs, saliva interference | Nitroglycerin, buprenorphine |
| Rectal | Variable; partial first-pass avoidance | Useful when oral not possible (vomiting) | Variable absorption, patient discomfort | Diazepam rectal gel, paracetamol suppositories |
🎯 Key Concept: Sublingual and rectal routes partially or completely bypass hepatic first-pass metabolism, providing higher bioavailability than oral administration.
💉 Parenteral Routes
Drug administration bypassing the GI tract for rapid and predictable effects:
| Route | Onset/Bioavailability | Advantages | Disadvantages | Clinical Use |
|---|---|---|---|---|
| Intravenous (IV) | Immediate; 100% bioavailability | Rapid, precise control, large volumes | Invasive, infection risk, irreversible | Emergencies, vasopressors, antibiotics |
| Intramuscular (IM) | 10–30 min; high but variable | Depot formulations, less technical than IV | Pain, bleeding risk, variable in shock | Vaccines, depot antipsychotics |
| Subcutaneous (SC) | 15–60 min; variable | Easy self-administration, safe | Limited volume, slower absorption | Insulin, heparin, biologics |
| Intrathecal/Epidural | Variable; direct CNS delivery | High CNS concentration, low systemic exposure | Invasive, infection risk, neurotoxicity | Spinal anesthesia, chemotherapy |
⚠️ Emergency Access: In shock or cardiac arrest when IV access fails, use intraosseous (IO) route for rapid drug delivery, especially in pediatrics and resuscitation scenarios.
🌬️ Other Administration Routes
Specialized routes for targeted delivery:
| Route | Characteristics | Clinical Applications | Examples |
|---|---|---|---|
| Inhalational | Rapid onset (minutes); local or systemic effect | Respiratory diseases, anesthesia | Salbutamol inhalers, volatile anesthetics |
| Transdermal | Slow onset; steady systemic delivery | Chronic therapy requiring stable levels | Nicotine patches, fentanyl patches |
| Topical | Quick local effects; minimal systemic absorption | Dermatologic conditions | Antibiotic ointments, steroid creams |
| Ophthalmic/Otic/Nasal | Local effect; some systemic via mucosa | Eye/ear infections, intranasal medications | Eye drops, intranasal fentanyl, ear drops |
📊 Comparative Pharmacokinetics
Quick reference for onset and bioavailability by route:
| Route | Typical Onset | Bioavailability | Primary Indication |
|---|---|---|---|
| IV | Immediate | 100% | Emergency, precise titration |
| Sublingual | Minutes | High (avoids first-pass) | Acute angina, rapid effect needed |
| Inhalation | Minutes | Variable (high local) | Respiratory disease, anesthesia |
| IM | 10–30 min | High but variable | Depot injections, vaccines |
| SC | 15–60 min | High but variable | Biologics, insulin, anticoagulants |
| Oral (PO) | 30–90 min | Variable (first-pass) | Chronic outpatient therapy |
| Transdermal | Slow (hours) | Moderate (steady) | Chronic systemic delivery |
| Rectal | Variable | Partial (some first-pass) | Vomiting, pediatric seizures |
🔍 Factors Influencing Drug Absorption
Key determinants of absorption efficiency:
Physiologic Factors
- Blood Flow: Higher perfusion increases absorption rate
- Surface Area: Larger area (lungs, intestines) enhances absorption
- Patient Age: Altered GI motility and perfusion in elderly
- Disease States: Malabsorption syndromes reduce oral bioavailability
Drug Properties
- Lipophilicity: Lipid-soluble drugs cross membranes easily
- Molecular Size: Smaller molecules absorb faster
- Ionization (pKa): Non-ionized forms cross membranes
- Formulation: Sustained-release delays absorption
⚠️ Clinical Tip: In hypotensive or shock patients, IM and SC absorption becomes unreliable due to poor perfusion. Use IV or intraosseous routes in emergencies.
🎯 Clinical Pearls
Essential high-yield principles for drug administration routes:
- IV route: immediate effect, 100% bioavailability; use for emergencies and precise control
- Sublingual/buccal: avoid first-pass metabolism; rapid onset for acute conditions (angina)
- Oral route: convenient for chronic therapy; subject to first-pass metabolism and food interactions
- IM absorption unreliable in shock; choose IV or intraosseous in hypotensive patients
- Transdermal: provides steady plasma levels; ideal for chronic therapy (nicotine, fentanyl)
- Inhalational: rapid onset for local lung delivery (bronchodilators) or systemic gases (anesthetics)
- Rectal route: useful when oral impossible (vomiting, unconsciousness, pediatric seizures)
- Intrathecal: direct CNS delivery with minimal systemic exposure; risk of neurotoxicity
- Consider patient condition (consciousness, GI function, perfusion) when selecting route
- Depot formulations (IM) provide sustained release for weeks to months
🔬 Pharmacology Study Tips:
- Speed ranking (fast to slow): IV > Sublingual > Inhalation > IM > SC > Oral > Transdermal
- Bioavailability rule: IV = 100%; oral = variable due to first-pass
- Emergency access: IV first; if fails, use intraosseous (especially pediatrics)
- First-pass avoidance: Sublingual, buccal, rectal (partial), IV, IM, SC